Cargando…

A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain

The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hifumi, Emi, Nonaka, Tamami, Taguchi, Hiroaki, Uda, Taizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649737/
https://www.ncbi.nlm.nih.gov/pubmed/36357546
http://dx.doi.org/10.1038/s41598-022-23689-6
_version_ 1784827862475341824
author Hifumi, Emi
Nonaka, Tamami
Taguchi, Hiroaki
Uda, Taizo
author_facet Hifumi, Emi
Nonaka, Tamami
Taguchi, Hiroaki
Uda, Taizo
author_sort Hifumi, Emi
collection PubMed
description The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cleaving an immune-check point PD-1 peptide and recombinant PD-1; however, H34wt does not contain His residues in the variable region. To clarify the reason behind the catalytic features of H34wt and the amino acid residues involved in the catalytic reaction, we performed site-directed mutagenesis focusing on the amino acid residues involved in the cleavage reaction, followed by catalytic activity tests, immunological reactivity evaluation, and molecular modeling. The results revealed that the cleavage reaction by H34wt proceeds through the action of a new catalytic site composed of Arg, Thr, and Gln. This new scheme differs from that of the serine protease mechanism of catalytic antibodies.
format Online
Article
Text
id pubmed-9649737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96497372022-11-15 A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain Hifumi, Emi Nonaka, Tamami Taguchi, Hiroaki Uda, Taizo Sci Rep Article The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cleaving an immune-check point PD-1 peptide and recombinant PD-1; however, H34wt does not contain His residues in the variable region. To clarify the reason behind the catalytic features of H34wt and the amino acid residues involved in the catalytic reaction, we performed site-directed mutagenesis focusing on the amino acid residues involved in the cleavage reaction, followed by catalytic activity tests, immunological reactivity evaluation, and molecular modeling. The results revealed that the cleavage reaction by H34wt proceeds through the action of a new catalytic site composed of Arg, Thr, and Gln. This new scheme differs from that of the serine protease mechanism of catalytic antibodies. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9649737/ /pubmed/36357546 http://dx.doi.org/10.1038/s41598-022-23689-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hifumi, Emi
Nonaka, Tamami
Taguchi, Hiroaki
Uda, Taizo
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title_full A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title_fullStr A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title_full_unstemmed A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title_short A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
title_sort new catalytic site functioning in antigen cleavage by h34 catalytic antibody light chain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649737/
https://www.ncbi.nlm.nih.gov/pubmed/36357546
http://dx.doi.org/10.1038/s41598-022-23689-6
work_keys_str_mv AT hifumiemi anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT nonakatamami anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT taguchihiroaki anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT udataizo anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT hifumiemi newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT nonakatamami newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT taguchihiroaki newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain
AT udataizo newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain